Picture of Kontafarma China Holdings logo

1312 Kontafarma China Holdings Cashflow Statement

0.000.00%
hk flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapValue Trap

Annual cashflow statement for Kontafarma China Holdings, fiscal year end - December 31st, HKD millions except per share, conversion factor applied.

2020
December 31st
2021
December 31st
2022
December 31st
2023
December 31st
2024
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:ARSARSARSARSARS
Standards:
HKAS
HKAS
HKAS
HKAS
HKAS
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line-0.297-0.326-118-43.9-98
Depreciation
Amortisation
Non-Cash Items188-54.1121-20.776.9
Discontinued Operations
Unusual Items
Equity in Net Earnings/Losses
Other Non-Cash Items
Changes in Working Capital-158-62-136-5.43-31
Change in Accounts Receivable
Change in Inventories
Change in Other Assets
Change in Accounts Payable
Change in Payable / Accrued Expenses
Change in Other Liabilities
Other Operating Cash Flow
Cash from Operating Activities20775.1-2.1737.147
Capital Expenditures-166-124-51.7-24.2-13.6
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items-39.91481731687.62
Acquisition of Business
Sale of Business
Sale of Fixed Assets
Sale/Maturity of Investment
Purchase of Investments
Sale of Intangible Assets
Other Investing Cash Flow
Cash from Investing Activities-20623.2122144-6.01
Financing Cash Flow Items-112-101-135-33-13.4
Other Financing Cash Flow
Net Issuance / Retirement of Debt
Cash from Financing Activities19.1-99.8-137-199-42.5
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash17.52.14-45.4-44.92.93